Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Advanced Medical Solutions Group PLC - Cheshire, England-based developer and maker of tissue-healing technology - Says 2022 revenue and profit will be in line with market expectations, as both business units - Surgical and Woundcare - ‘perform well’. In 2021, Advanced Medical Solutions recorded pretax profit of £22.0 million on revenue of £108.6 million. For the first half of 2022, these were £12.3 million and £58.3 million, respectively. Results for all of 2022 will be posted on March 15.
Says that over two-thirds of the patients have been recruited for the initial European Seal-G clinical trial, which is on track for completion in the first half of this year. ‘The underlying momentum throughout the group, which has been further strengthened with promising new products, gives us confidence of meeting market expectations for 2023 and sustaining our growth profile in the long term,’ says Chief Executive Officer Chris Meredith.
Current stock price: 266.43 pence, up 0.5%
12-month change: down 14%
By Tom Waite, Alliance News editor
Comments and questions to newsroom@alliancenews.com
Copyright 2023 Alliance News Ltd. All Rights Reserved.